PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung disease |
| Phenotype | C0003864|arthritis |
| Sentences | 19 |
| PubMedID- 24378059 | [effect of selective phosphodiesterase 4 inhibitors on nuclear factor kappa b, tumor necrosis factor-alpha and interleukin-8 expression in peripheral blood mononuclear cells in rheumatoid arthritis with interstitial lung disease]. |
| PubMedID- 22265461 | Rheumatoid nodules are a rare manifestation of lung disease associated with rheumatoid arthritis (ra). |
| PubMedID- 24200605 | Extra-muscular manifestations such as dermatitis, arthritis, interstitial lung disease (ild), cardiomyopathy, and enteropathy are occasional complications in patients with pm/dm. |
| PubMedID- 21325762 | Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of pneumocystis pneumonia in japan revealed by a multicenter study. |
| PubMedID- 25665185 | Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. |
| PubMedID- 22341526 | Objective: to describe the evolution of lung function in a cohort of rheumatoid arthritis (ra) patients with interstitial lung disease (ild) treated according to the medical judgment of attending physicians. |
| PubMedID- 20522855 | The use of abatacept in debilitating cavitating lung disease associated with rheumatoid arthritis, bronchocentric granulomatosis and aspergillosis. |
| PubMedID- 20884744 | The outcome and cause of death of each lung disease directly associated with rheumatoid arthritis (ra-ld) have been poorly investigated. |
| PubMedID- 22806097 | We also present a third clinical entity, that of lung disease associated with rheumatoid arthritis (rheumatoid lung), representing a condition that can manifest as either phenotype, and offering a potential opportunity to explore the mechanisms underlying the pathogenesis of the two distinct fibrotic phenotypes. |
| PubMedID- 22084614 | We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside. |
| PubMedID- 20480164 | A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab. |
| PubMedID- 24521636 | Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study. |
| PubMedID- 25746669 | A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in chinese patients. |
| PubMedID- 26401101 | Management of rheumatoid arthritis patients with interstitial lung disease: safety of biological antirheumatic drugs and assessment of pulmonary fibrosis. |
| PubMedID- 22185348 | Rheumatoid arthritis-associated interstitial lung disease (ra-ild) is associated with increased mortality in up to 10% of patients with rheumatoid arthritis. |
| PubMedID- 25417684 | Abatacept therapy in rheumatoid arthritis with interstitial lung disease. |
| PubMedID- 25744479 | Backgrounds: interstitial lung disease (ild) is associated with rheumatoid arthritis (ra) itself and is also induced by biological and non-biological disease-modifying antirheumatic drugs. |
| PubMedID- 20851924 | However, mortality rates from rheumatoid arthritis-associated interstitial lung disease increased 28.3% in women (to 3.1 per million persons in 2004) and declined 12.5% in men (to 1.5 per million persons in 2004). |
| PubMedID- 25922727 | Changes in peripheral cd19(+)foxp3(+) and cd19(+)tgfbeta(+) regulatory b cell populations in rheumatoid arthritis patients with interstitial lung disease. |
Page: 1